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Analysis of HIV-1-X4 Fusion with Immature Dendritic
Cells Identifies a Specific Restriction that Is
Independent of CXCR4 Levels
Marjorie Pion1,2, Jean-Francois Arrighi1,2, Jiyang Jiang3, Christopher A. Lundquist3, Oliver Hartley4,
Christopher Aiken3 and Vincent Piguet1,2
Immature dendritic cells (iDCs) are likely to be among the first targets of HIV infection during sexual
transmission. We analyzed whether the relatively inefficient viral replication in iDCs could be attributed to
specific restrictions during the viral life cycle. Using iDCs from a panel of donors, we set out to compare their
capacity to support infection and propagation of X4- and R5-tropic viruses. We also performed quantitative flow
cytometry to determine levels of relevant cell-surface CD4 and HIV-1 co-receptors. Although iDCs express
comparable levels of functional CXC chemokine receptor 4 (CXCR4) and CC chemokine receptor 5 (CCR5) at
the cell surface, they are 100- to 1,000-fold less susceptible to infection by X4- versus R5-tropic HIV-1 strains.
Increasing surface expression of CXCR4 by transduction with lentiviral vectors did not lead to increased
replication of the X4-tropic strains. Fusion of HIV-X4 with iDCs was markedly less efficient compared to that of
HIV-R5. We conclude that an env-specific block early in the viral cycle operates in iDCs. This restriction may play
a role in the exclusion of X4-tropic strains during HIV-1 transmission.
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INTRODUCTION
During the early events of HIV-1 infection, most notably
during sexual transmission, model systems have demon-
strated that the first cellular targets of HIV are dendritic cells
(DCs) (reviewed by Piguet and Blauvelt, 2002; Steinman
et al., 2003). After encountering virus, DCs migrate from the
periphery to the lymph nodes where they efficiently transmit
HIV to CD4þ T cells. The term ‘‘DC’’ includes several
subpopulations such as Langerhans cells and myeloid dermal
DCs that contribute to the diversity of DC subsets that are
observed in vivo (reviewed by Banchereau and Steinman,
1998). At steady state, DCs are present in the skin and
mucosal tissues in an immature state until they encounter
pathogens.
HIV infection of DCs, both in vivo and in vitro, has been
relatively difficult to detect because viral replication in DCs
occurs at much lower levels than in CD4þ T cells (reviewed
by Piguet and Blauvelt, 2002). HIV can infect Langerhans
cells and other types of myeloid DCs in vitro, at least when
relatively high viral inocula are used (Pope et al., 1995;
Kawamura et al., 2000). However, the mechanisms under-
lying the relatively poor replication of HIV in immature DCs
(iDCs) have not been yet identified.
In this study, we investigated whether specific restrictions
in the HIV-1 life cycle account for the limited HIV-1
replication in iDCs. Our results demonstrate that replication
of HIV-1 using CXC chemokine receptor 4 (CXCR4) (HIV-X4)
in iDCs is much less efficient than that of HIV-R5-tropic
strains. This env-specific restriction is not due to a lack of
either CD4 or co-receptors, but rather to a block early in the
viral life cycle, during the fusion process. It may play a role
in the exclusion of HIV-X4 during person-to-person
transmission.
RESULTS
HIV-X4 replication is restricted in iDCs
We generated immature monocyte-derived DCs after 6 days
of culture of monocytes in GM-CSF and IL-4 as described
previously (Arrighi et al., 2004a; Garcia et al., 2005). iDCs
were consistent with expected phenotypes.
HIV-X4 generally infects DCs inefficiently. Although a multi-
plicity of infection of 0.001 was sufficient for efficient repli-
cation of HIV-X4 in phytohemagglutinin-L (PHA-L)-activated
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peripheral blood lymphocytes (PBLs), 500- to 1,000-fold
greater concentrations of HIV-1 were required for productive
infection of iDCs (Figure 1a). These results confirm previous
reports that iDCs are poorly permissive to infection by
HIV-X4 (Granelli-Piperno et al., 1998; Canque et al., 1999;
Smed-Sorensen et al., 2005).
The differential permissiveness of iDCs to infection by
HIV-X4 versus HIV-R5 suggested that differences in the levels
of HIV receptor (CD4) and co-receptor (CXCR4) might
explain the inefficient replication of HIV-X4 in iDCs. To test
this, we analyzed the presence of HIV receptors and co-
receptors on iDCs prepared from 29 donors by cell-surface
antibody staining and flow cytometry. In most of the samples,
CD4 and both CC chemokine receptor 5 (CCR5) and CXCR4
were expressed at the cell surface (Table S1b). CXCR4 and
CCR5 were present on CD1aþ cells as well as dendritic cell-
specific ICAM-3 grabbing non-integrin (DC-SIGN)-positive
cells (data not shown). To quantify the cell-surface expression
of CXCR4 and CCR5, we performed quantitative FACS
(QFACS) analysis of these receptors in five (activated PBLs)
and 10 (iDCs) representative donors as described previously
(Lee et al., 1999). QFACS allows results from independent
experiments to be compared and also provides the average
number of receptor molecules per cell. CXCR4, CCR5, and
CD4 were expressed on iDCs at levels that were well above
the background level of this QFACS assay (approximately
1,000, depending of the antibody used). Analysis by QFACS
revealed similar levels of CD4, CCR5, and CXCR4 on iDCs
and PHA-L-activated PBLs (Figure 1b). Although most DCs
expressed CD4, only 15–20% expressed CXCR4 (Table S1b).
Total antibody-binding sites (ABS) were calculated by multi-
plying the ABS value by the percentage of positive cells for a
specific receptor in the total cell population. On average on
total ABS, iDCs exhibited 7- to 10-fold lower levels of CXCR4
at their surface relative to activated PBLs (Figure 1b). Most
iDCs expressed CD4 and the levels of CD4 were approxi-
mately 2-fold lower in iDCs than activated PBLs. As
expected, CCR5 was well expressed on iDCs and barely
detectable on activated PBLs (Figure 1b). Based on these
results, we conclude that iDCs express sufficient quantities of
CD4 to support entry of HIV-X4 virus, however, iDCs express
7- to 10-fold lower levels of CXCR4 than activated PBLs.
Ectopic expression of CXCR4 does not enhance iDC
permissiveness to HIV-X4 infection
As the modest difference in CD4 expression levels was
unlikely to explain the 100- to 1,000-fold deficit in HIV-X4
replication in iDCs, we evaluated whether CXCR4 levels on
iDCs were limiting. Although CXCR4 was expressed on iDCs,
its levels (total ABS) were approximately 7- to 10-fold lower
than in activated PBLs. To boost the levels of CXCR4
expression, we transduced iDCs with a lentiviral vector
encoding CXCR4. Typically, in these conditions, 80–90% of
the iDCs were transduced and expressed high levels of
CXCR4 at their surface (Figure 2a and b). Ectopic expression
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Figure 1. HIV-X4 replicates inefficiently in iDCs. (a) Assay of HIV-X4
replication by intracellular labeling of p24gag. iDCs are 500-fold less
susceptible than activated PBLs to HIV-X4 replication. Results are
representative of three independent experiments (7SD). (b) CXCR4 is 7-
to 10-fold lower on iDCs than on activated PBLs. Representation of total
ABS of HIV receptors CD4, CCR5, and CXCR4 on the cell surface of
PHA-L-activated PBLs and iDCs. Results are representative of five and
10 independent experiments for PBLs and iDCs, respectively.
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Figure 2. Ectopic expression of CXCR4 does not restore HIV-X4 replication
in iDCs. (a) Ectopic expression of CXCR4 on iDCs increases CXCR4
expression to levels equal to activated PBLs. Surface labeling of iDCs, CXCR4-
transduced iDCs (iDC-CXCR4), and PHA-L-activated PBLs after 2 days of
transduction with CXCR4-encoding lentivectors. (b, left) Representation of
total ABS of CD4, CCR5, and CXCR4 on iDCs and iDC-CXCR4. Results are
representative of four independent experiments (7SEM). (b, right) HIV-X4
does not replicate efficiently in iDCs or iDC-CXCR4. Infection was detected
by intracellular p24gag after 6 days of infection by HIV-X4 (R9). Results are
representative of two independent experiments (7SD).
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of CXCR4 in iDCs (iDC-CXCR4) increased levels of CXCR4 to
levels slightly higher than those on activated PBLs (Figure 2a
and b). However, HIV-X4 replication remained inefficient in
CXCR4-overexpressing iDCs (Figure 2c). It is likely that the
ectopic CXCR4 on the transduced iDCs was present in a
native conformation, as AMD3100, a highly selective
inhibitor of CXCR4, potently blocked binding of CXCR4
antibody (12G5) to both iDCs or iDC overexpressing CXCR4
(Figure S1). We conclude that the lower levels of CXCR4 on
the surface of iDCs versus activated PBLs do not account for
the low permissiveness of iDCs to HIV-X4.
HIV-R5 replicates in iDCs
As our iDCs consistently expressed CD4, CXCR4, and CCR5,
we evaluated the capacity of these cells to support the
replication of several HIV-R5 (R8Ba-L, YU-2, AD8) and
HIV-X4 (R9, NDK, NL4-3) strains. HIV-1 replication was
measured by intracellular p24gag assays of infected iDCs
(Figure 3a and b). Whereas HIV-R5 strains replicated in iDCs
even following inoculation with a multiplicity of infection of
0.1 (Figure 3a and b), these cells were poorly permissive to
HIV-X4 strains (Figure 3a and b). These results confirm the
differential susceptibility of iDCs to X4- and R5-tropic HIV-1
strains.
Collectively, these results indicate that HIV-X4 replication
in iDCs is very inefficient despite the fact that both CD4 and
CXCR4 are expressed on the cells. Stimulation of CCR5 did
not rescue the deficit of replication of HIV-X4, indicating that
CCR5-mediated intracellular signaling was not sufficient to
promote HIV-X4 replication in iDCs (data not shown).
Fusion of HIV-X4 with iDCs is restricted
To determine directly whether the low permissiveness of
iDCs for infection by HIV-X4 is due to inefficient entry of the
virus, we quantified the ability of X4- and R5-tropic HIV-1 to
fuse with iDCs, using an established reporter assay of HIV-1
virus–cell fusion (Cavrois et al., 2002; Wyma et al., 2004)
HIV-X4 (R8) fused efficiently with CD4þ T cells and SupT1-
CCR5 cells (better than HIV-R5 (R8Ba-L)) (Figure 4, left,
center). Fusion of HIV-R5 with iDCs was readily detectable,
with signals that were 3- to 5-fold higher than that observed
with the env-deficient HIV-1 control virus (Figure 4, right).
The signal was blocked by T-20, a peptide inhibitor of HIV-1
fusion, demonstrating that the assay detected fusion mediated
by the HIV-1 envelope proteins. On the other hand, HIV-X4
fusion with iDCs was very close to background levels,
indicating that HIV-X4 fusion with iDCs is restricted.
Although we cannot exclude the possibility that some fusion
occurs below the detection limit of the assay, these results
clearly indicate that compared to HIV-R5, HIV-X4 shows a
significantly lower capacity to undergo fusion with iDCs.
Hence, it is likely that HIV-X4 fusion is specifically restricted
in iDCs.
Reverse transcription and integration were also decreased
for HIV-X4 (Figure S2), consistent with the fact that HIV-X4
fusion is specifically restricted in iDCs. Together, these
findings demonstrate an env-specific block for HIV-X4
replication in iDCs early in the viral life cycle.
DISCUSSION
In this study, we investigated the poor susceptibility of iDCs
to replication of HIV-X4. Activated PBLs are at least 100- to
1,000-fold more susceptible to HIV-X4 replication than iDCs.
Furthermore, iDCs exhibit a specific restriction to infection by
X4- versus R5-tropic HIV-1. By analysis of HIV replication in
iDCs, we observed a strong restriction of HIV-X4 viral
replication at the stage of virus fusion.
We demonstrated by QFACS analysis that our monocyte-
derived iDCs expressed CXCR4 at lower levels (5- to 10-fold
lower) when compared to activated PBLs. Importantly, we
demonstrate here that even in the presence of CD4 and both
co-receptors (CCR5/CXCR4), viral replication in iDCs is
severely restricted for HIV-X4 when compared to HIV-R5 in
iDCs and in activated PBLs.
Using a reporter assay of HIV-1 virus–cell fusion (Cavrois
et al., 2002; Wyma et al., 2004), we detected fusion of HIV-
R5 with iDCs. By contrast, a convincing signal was not
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Figure 3. HIV-R5 replicates in iDCs. (a) Viral replication of HIV-X4 (NDK)
and HIV-R5 (YU-2) in iDCs measured by intracellular p24gag FACS analysis
6 days post-inoculum (multiplicity of infection: 1) in the presence or absence
of 30-azido-30-deoxythymidine. One representative experiment of three is
shown. (b) Percentage of iDCs infected (measured by intracellular p24gag
FACS) by HIV-X4 strains (R9, NDK, NL4.3) and HIV-R5 strains (R8Ba-L, AD8,
YU-2). Results represent the mean of three independent experiments (7SEM).
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Figure 4. Fusion of HIV-X4 with iDCs is restricted. SupT1-CCR5, CD4þ
T cells, and iDCs were infected with HIV-X4 (R8) or HIV-R5 (R8Ba-L)
containing a Vpr-b lactamase fusion protein. Viral fusion with SupT1 (left),
CD4þ T (center), and iDCs (right) was monitored by differential fluorescence
between cleaved (blue) and non-cleaved (green) substrate (CCF2/AM) in
iDCs. Pretreatment with T-20 as well as env-deficient (‘‘delta Env’’) viral
strains were included as controls. One representative experiment of two
is shown.
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observed when HIV-X4 particles were assayed. However, the
same HIV-X4 particles were highly active for fusion with
primary CD4þ T cells. We conclude that a primary block to
HIV-X4 infection of iDCs is at the level of cell entry. Our
study extends the study of Cavrois et al. (2006) by
demonstrating that the levels of CD4 and CXCR4 on the
surface of iDCs do not simply explain the limited fusion of
HIV-X4 with iDCs.
Why HIV-X4 fusion with iDCs is so inefficient remains
unclear given that iDCs express detectable levels of both CD4
and CXCR4. The relatively low levels of CXCR4 do not
appear to be a limiting factor, as overexpression of CXCR4 on
iDCs did not lead to enhanced infection. Surface levels of
CD4, which are very similar to those seen on activated PBLs,
are unlikely to be limiting. The small (2-fold) reduction in
surface CD4 is unlikely to explain the poor replication of
HIV-X4 in iDCs (100- to 1,000-fold less replication than in
activated PBLs), especially given that HIV-R5 uses the same
CD4 levels to replicate relatively well. One possibility is that
fusion of HIV-X4 might be limited in iDCs because they lack
cellular cofactors required for viral fusion. For example,
evidence for a role of cell-surface protein disufide isomerase
in HIV-1 fusion was reported (Gallina et al., 2002). Whether
iDCs have a defect in protein disufide isomerase, or other
putative fusion cofactors, remains to be determined.
Other cells of the monocyte lineage also restrict HIV
infection. HIV nuclear entry is blocked in monocytes (Neil
et al., 2001) and studies of HIV-1 replication in these cells
demonstrated that an inefficient synthesis of full-length viral
cDNAs occurred in these cells (Triques and Stevenson, 2004).
However, in monocytes, there was apparently no block
during viral fusion and uncoating (Triques and Stevenson,
2004). The restriction of HIV-1-X4 infection of iDCs is
reminiscent of HIV-1 infection of monocyte-derived macro-
phages. In monocyte-derived macrophages, CD4, CCR5, and
CXCR4 are also expressed at the cell surface. Macrophages
are permissive to infection by R5-tropic strains of HIV-1, but
not most X4-tropic strains. Studies of HIV-1-X4 infection of
macrophages have attributed the block to both entry and
post-entry stages of the virus life cycle. In a recent study using
the BlaM-Vpr HIV-1 fusion assay, X4-tropic HIV-1 strains
were poorly able to fuse with monocyte-derived macro-
phages (Jiang and Aiken, 2006). This phenotype is similar to
that observed in iDCs in this study, and suggests that iDCs
and monocyte-derived macrophages may restrict HIV-1-X4
entry by a common mechanism.
There is evidence to suggest that a gatekeeping pheno-
menon operates during person-to-person HIV transmission,
restricting the propagation of strains using CXCR4 as a co-
receptor relative to those that use CCR5 probably via multiple
restrictions (reviewed by Moore et al., 2004; Margolis and
Shattock, 2006). Although our iDCs preparations are not
identical to Langerhans cells in mucosal epithelia, it is
possible that similar restrictions to HIV-X4 fusion occur in
Langerhans cells, providing an additional level of restriction
to HIV-X4 during HIV-1 person-to-person HIV transmission.
In conclusion, we demonstrated that HIV-X4 replication
in iDCs was restricted at the level of fusion, and that
this phenomenon is not simply due to lack of
CXCR4. Whether iDCs express cellular machinery that
specifically restricts HIV-X4 replication, or whether they
lack appropriate cofactors required during the early events of
the viral life cycle are two exciting questions that remain to
be answered. The precise analysis of HIV-1 replication in
iDCs may provide essential knowledge for the development
of novel therapeutic strategies to prevent HIV sexual
transmission.
MATERIALS AND METHODS
Chemokines
RANTES and SDF-1aN33A were produced by total chemical
synthesis, essentially as described (Wilken et al., 1999). The N33A
variant of SDF-1a does not differ in its pharmacological properties
from native SDF-1a.
Virus stocks production
All virus stocks were produced by transient transfection of 293T
cells as described previously (Arrighi et al., 2004b). pR9 and pR8
are full-length HIV-1-X4 molecular clones. pR8Ba-L is a full-length
HIV-1-R5 molecular clone in which the R5-tropic envelope of strain
HIV-1-Ba-L has replaced the X4-tropic envelope of R9. Detailed
information is available on-line in Supplementary material.
Preparation of human primary DCs
Monocytes from buffy coats of healthy donors (obtained according to
the institutional guidelines of the ethical committee of the University
of Geneva) were isolated and processed as described previously
(Garcia et al., 2005). Patients gave informed consent and experi-
ments adhered to the Declaration of Helsinki Principles. Contam-
ination of our DC cultures by CD3þ T cells was lower than 0.5%
(Table S1). Detailed protocols are available on-line in Supplemen-
tary material.
Quantitive flow cytometric analysis
QFACS analysis was performed as described by Lee et al. (1999),
using similar antibodies. Quantification was performed by convert-
ing the mean channel fluorescence into ABS by using a standardized
microbeads kit according to the manufacturer’s instructions (Sigma-
Aldrich, Buchs, Switzerland). Total ABS was obtained by multiplying
the ABS value by the percentage of positive cells in the total
cell population. Antibodies used were 13B8.2, antigen-presenting
cell-conjugated anti-CD4; 2D7, antigen-presenting cell-conjugated
anti-CCR5; 12G5, antigen-presenting cell-conjugated anti-CXCR4;
and DCN46, FITC-conjugated anti-DC-SIGN (all from Pharmingen,
San Jose, CA).
Infection assays
Detailed protocols are available on-line in Supplementary material.
Briefly, viral replication was monitored by titration on the HeLa-
P4.2-R5 indicator cell line, by assay of reverse transcriptase activity
in supernatants of infected cells or by FACS analysis of intracellular
p24gag as described by Arrighi et al. (2004a).
In order to generate lentiviral vectors expressing CXCR4, we
subcloned a cDNA encoding CXCR4 (obtained through the AIDS
research and reference reagent program, Division of AIDS, NIAID,
NIH, pc-fusin from Dr Nathaniel Landau (Deng et al., 1996)) into
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pLOX vector (Salmon et al., 2000). High-titer lentiviral vectors were
generated as described previously (Arrighi et al., 2004a).
Flow cytometric analysis
iDCs were analyzed by flow cytometric analysis as described
previously (Arrighi et al., 2004b). Detailed protocols are available
on-line in Supplementary material.
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